Hypolipidemic effect of hexane fraction from rhizopus oryzae KSD-815 through peroxisome proliferator-activated receptor-α

Journal of Applied Biological Chemistry

Volumn 53, Issue 6, 2010, Pages 761-765

  Lee, Sang Jin ^a,b   Kim, Gye Won ^a  

^a Kooksoondang Brewery Co Ltd   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Apolipoprotein A1; Hyperlipidemia; Nuruk; Obesity; Peroxisome proliferator activated receptors; Rhizopus oryzae KSD 815

Indexed keywords

RATTUS; RHIZOPUS ORYZAE;

EID: 78751484907     PISSN: 19760442     EISSN: None     Source Type: Journal    
DOI: 10.3839/jksabc.2010.115     Document Type: Article

References (21)

1. Braissant O, Foufelle F, Scotto C, Dauca M, and Wahli W (1996) Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPARalpha,- beta, and-gamma in the adult rat. Endocrinology 137, 354-366.
2. Brun RP, Tontonoz P, Forman BM, Ellis R, Chen J, Evans RM, and Spiegelman BM (1996) Differential activation of adipogenesis by multiple PPAR isoforms. Gene Dev 10, 974-984.
3. Chen X, Matthews J, Zhou L, Pelton P, Liang Y, Xu J, Yang M, Cryan E, Rybczynski P, and Demarest K (2008) Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator activated receptor agonist. Metabolism 57, 1516-1525.
4. Chung KS, Oh WT, Nam SM, Son BS, and Park YS (1998) Effect of Korean rice-wine (Yakju) on in vitro and in vivo progression of B16BL6 mouse melanoma and HRT18 human colon adenocarcinoma cells. Korean J Food Sci Technol 30, 1470-1475.
5. Doebber TW, Kelly LJ, Zhou G, Meurer R, Biswas C, Li Y, Wu MS, Ippolito MC, Chao YS, Wang PR, Wright SD, Moller DE, and Berger JP (2004) MK-0767, a novel dual PPARalpha/gamma agonist, displays robust antihyperglycemic and hypolipidemic activities. Biochem Biophys Res Commun 318, 323-328.
6. Huttunen JK, Manninen V, Manttari M, Koskinen P, Romo M, Tenkanen L, Heinonen OP, and Frick MH (1991) The Helsinki Heart Study: central findings and clinical implications. Ann Med 23, 155-159.
7. Kim MK, Chae YN, Son MH, Kim SH, Kim JK, Moon HS, Park CS, Bae MH, Kim E, Han T, Choi HH, Shin YA, Ahn BN, Lee CH, Kim JI, and Shin CY (2008) PAR-5359, a well-balanced PPARα/γ dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo. Eur J Pharmacol 595,119-125.
8. Kim SJ, Ko SH, Lee WY, and Kim GW (2004a) Cytotoxic effects of Korean rice-wine (Yakju) on cancer cells. Korean J Food Sci Technol 36, 812-817.
9. Kim SJ, Baek JY, Park CK, and Kim GW (2004b) Gastroprotective effect of Korean rice-wine (Yakju). Korean J Food Sci Technol 36, 818-822.
10. Lee SJ, Bae HJ, Ryu JY, Lee DY, Kim GW, Baek NI, Kwon MS, and Hong SY (2009) Extracts from Rhizopus oryzae KSD-815 of Korean Traditional Nuruk Confer the Potential to Inhibit Hypertension, Platelet Aggregation, and Cancer Metastasis in vitro. Food Sci Biotechnol 18, 1423-1429.
11. Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, Linares E, Schaefer EJ, and Schectman G (1999) Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of highdensity lipoprotein cholesterol. New Engl J Med 341, 410-418.
12. Sakamoto J, Kimura H, Moriyama S, Odaka H, Momose Y, Sugiyama Y, and Sawada H (2000) Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone. Biochem Biophys Res Commun 278, 704-711.
13. Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, and Fruchart JC (1998) Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98, 2088-2093.
14. Tontonoz P, Hu E, Graves RA, Budavari AI, and Spiegelman BM (1994) mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Gene Dev 8, 1224-1234.
15. Torra IP, Gervois P, and Staels B (1999) Peroxisome proliterator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging. Curr Opin Lipidol 10, 151-159.
16. van Wijk JP, de Koning EJ, Martens EP, and Rabelink TJ (2003) Thiazolidinediones and blood lipids in type 2 diabetes. Arterioscler Thromb Vasc Biol 23, 1744-1749.
17. Venkatesh P, Harisudhan T, Choudhury H, Mullangi R, and Srinivas NR (2006) Simultaneous estimation of six antidiabetic drugs-glibenclamide, gliclazide, glipizide, pioglitazone, repaglinide and rosiglitazone: development of a novel HPLC method for use in the analysis of pharmaceutical formulations and its application to human plasma assay. Biomed Chromatogr 20, 1043-1048.
18. Watts GF and Dimmitt SB (1999) Fibrates, dyslipoproteinaemia and cardiovascular disease. Curr Opin Lipidol 10, 561-574.
19. Xu HE, Lambert MH, Montana VG, Plunket KD, Moore LB, Collins JL, Oplinger JA, Kliewer SA, Gampe RT, McKee DD, Moore JT, and Willson TM (2001) Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 98, 13919-13924.
20. Yoon CG, Chae SN, Huh NE, Kim HS, and Yu TS (1999) Effects of Nuruk or wheat bran supplemented diet on the serum levels of cholesterol and activities of hepatic oxygen free radical metabolizing enzymes rats. J Korean Soc Food Sci Nutr 28, 212-217.
21. Yoon M (2009) The role of PPARa in lipid metabolism and obesity: Focusing on the effects of estrogen on PPARα actions. Pharmacol Res 60, 151-159.